News
- Author:
- Sara Freeman
Publish date: May 7, 2019
BIRMINGHAM, ENGLAND – Monitoring biologic blood levels may have potential for lowering infection risk in rheumatoid arthritis.
News
- Author:
- Sara Freeman
Publish date: April 9, 2019
A telementoring and medical education program could help address the national shortage of rheumatologic care for underserved patients.
News
- Author:
- Sara Freeman
Publish date: February 17, 2019
LONDON – A group of prominent female physicians and thought-leaders discuss cultural changes needed to address gender inequality in science and med...
News
- Author:
- Sara Freeman
Publish date: February 13, 2019
Training is a “pinch point” with multiple factors at play which stack up until a threshold is reached that results in the impetus to leave.
News
- Author:
- Sara Freeman
Publish date: February 13, 2019
LONDON – Female investigators are less likely to secure research funding than men simply because they are women, according to research published in...
News
- Author:
- Sara Freeman
Publish date: January 24, 2019
BERLIN – Oral semaglutide was superior to placebo in reducing glycated hemoglobin at all doses tested, with weight loss benefits at the highest dos...
News
- Author:
- Sara Freeman
Publish date: December 13, 2018
BERLIN – Real-world data provide reassurance that currently used DMTs help reduce the risk of relapse in multiple...
News
- Author:
- Sara Freeman
Publish date: December 5, 2018
BERLIN – An increase in lower extremity amputations was seen among patients with type 2 diabetes mellitus who were treated with diuretics.
News
- Author:
- Sara Freeman
Publish date: November 27, 2018
BERLIN – Early infratentorial and deep white matter lesions after a clinically isolated syndrome were associated ...
News
- Author:
- Sara Freeman
Publish date: November 26, 2018
BERLIN – In the first year after the initiation of continuous glucose monitoring, hypoglycemia episodes needing external help were significantly re...
News
- Author:
- Sara Freeman
Publish date: November 20, 2018
BERLIN – Severe hypoglycemia was reversed successfully in all patients with type 1 diabetes mellitus given nasal glucagon.
News
- Author:
- Sara Freeman
Publish date: November 15, 2018
BERLIN – Risk factors for higher disease activity include younger age at diagnosis, shorter disease duration, and stopping more than 2 months befor...
News
- Author:
- Sara Freeman
Publish date: November 14, 2018
BERLIN – Switching to alemtuzumab from fingolimod or natalizumab is associated with fewer relapses and lesions in...
News
- Author:
- Sara Freeman
Publish date: November 9, 2018
BERLIN – Across a wide age range, closed-loop insulin delivery improved glycemic control and reduced hypoglycemia risk versus sensor-augmented pump...
News
- Author:
- Sara Freeman
Publish date: October 30, 2018
BERLIN – Escalating rather than switching to a similarly effective treatment results in fewer relapses in relapsi...
